hrs4r
 I want to donate

Internal Medicine is the main medical discipline in the care of adults with one or several complex acute or chronic diseases. The main areas of action are the complex chronic patient, acute patient, medical and surgical unit support, management of multi-organ diseases and the diagnosis and management of poorly defined syndromic pictures and minority diseases. Our Internal Medicine Service manages 1300 annual discharges, 1100 hospital interconsultations and 800 first visits to outpatient clinics. The main DRGs are infectious diseases, cardiac insufficiency and venous thromboembolic disease, as well as systemic-autoimmune diseases due to their idiosyncrasy.

From this environment arises the type of research in which the group feels involved, basically clinical-epidemiological to better understand the risk factors, diagnosis, treatment and prognosis of the pathologies that we assist.

Currently the staff is made up of 14 doctors with a post and 7 resident doctors. Most of them are interested and involved in research.

Main lines of research
  • Venous thromboembolic disease
  • Infectious Diseases: COVID-19, AIDS, MTS, Tuberculosis, ARI/Pneumonia.
  • Cardiac insufficiency
  • Autoimmune-systemic diseases.
Strategic objectives
  • Clinical-epidemiological research
  • Participation in National Registries
  • Participation in Phase II-III Clinical Trials
  • Development of Doctoral Theses
Publications
0

Persons with SARS-CoV-2 during the First and Second Waves in Catalonia (Spain): A Retrospective Observational Study Using Daily Updated Data.

JMIR Public Health and Surveillance, 2022, 8 dx.doi.org/10.2196/30006

Álvarez Bravo G, Sánchez Cirera L, Angerri Nadal M, Ramió I Torrentà L

Clinical heterogeneity in patients with myoclonus associated to COVID-19.

NEUROLOGICAL SCIENCES, 2022, 43, 1587-1592 dx.doi.org/10.1007/s10072-021-05802-1

González-Franco Á, Cerqueiro González JM, Arévalo-Lorido JC, Álvarez-Rocha P, Carrascosa-García S, Armengou A, Guzmán-García M, Trullàs JC, Montero-Pérez-Barquero M, Manzano L, RICA registry investigators

Morbidity and mortality in elderly patients with heart failure managed with a comprehensive care model vs. usual care: The UMIPIC program.

Revista Clinica Espanola, 2022, 222, 123-130 dx.doi.org/10.1016/j.rceng.2021.05.007
0

Post-COVID-19 patients show an increased endothelial progenitor cell production.

Translational Research : The Journal Of Laboratory And Clinical Medicine, 2022, 243, 14-20 dx.doi.org/10.1016/j.trsl.2022.01.004
0

Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain.

Global Epidemiology, 2022, 4, 100071-100071 dx.doi.org/10.1016/j.gloepi.2022.100071

Giorgi-Pierfranceschi M, Monreal M, Di Micco P, Francisco I, Hernández-Blasco L, Madridano O, López-Sáez JB, Hernando E, Meireles J, Dentali F, The Riete Investigators

Prognostic Impact of Active Cigarette Smoking on Mortality in Patients with Acute Venous Thromboembolic Events, Findings from Real World Data.

Medicina-Lithuania, 2022, 58 dx.doi.org/10.3390/medicina58020295
0

An interventional nationwide surveillance program lowers postoperative infection rates in elective colorectal surgery. A cohort study (2008-2019).

INTERNATIONAL JOURNAL OF SURGERY, 2022, 102, 106611-106611 dx.doi.org/10.1016/j.ijsu.2022.106611
0

Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid Tumors.

THROMBOSIS AND HAEMOSTASIS, 2022, 122, 1594-1602 dx.doi.org/10.1055/a-1777-4006
0

Nutritional Niches of Cancer Therapy-Induced Senescent Cells.

Nutrients, 2022, 14 dx.doi.org/10.3390/nu14173636
0

Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.

Journal of Clinical Medicine, 2022, 11 dx.doi.org/10.3390/jcm11195632
Competitive projects
Codi oficial: 101046118 Start date:01/12/2021 Data fi: 31/05/2024 Investigador/a principal: ANTONI CASTRO GUARDIOLA Organisme finançador: EUROPEAN COMISSION Ajuda: 378,125 €
Job offers

Team

If you are a researcher and you are interested in collaborating with any of our research groups, please fill in this form.
I am interested in
If you are a student or you want to do an internship with any of our research groups, please fill in this form.
I am interested in

About IDIBGI!

menu